Strategic Directions and Regional Impacts
The HIV/AIDs epidemic remains a major public health concern in the World Health Organisation South-East Asia Region. The 11-member states in the region are home to an estimated 3.5 million people living with HIV and has the second largest HIV population after sub-Saharan Africa. Raising public awareness in sexual health, tackling sensitive health issues and needle and syringe program efforts need to be scaled up. At such, Neo-Health utilize a highly replicable model which can adopted across different cities and countries, offering substantial market opportunities with huge global potential.

Apart from HIV/AIDs, other Sexual Transmitted Infections (STIs) prevalence is also high and rising. The market is lack of experts and support as the increasing demand from middle class seeks for greater privacy and dignity in the care-giving process. STIs can have a profound impact on sexual and reproductive health worldwide, with each year an estimated 357 million new infections to be either Chlamydia, Gonorrhea, Syphilis or Trichomonas. We will continue to provide education and social responsibility, sexual health screening, fast & accurate testing, treatment and R&D to fulfill the satisfaction of our clients.

In the coming years, we are hoping to take our business to an all time high with the introduction of a newly developed Cloud-based Clinic Management System (CMS) with the ability to view patient’s reports and interact with patient in the palm of their hand, anywhere, anytime. This system provides an even more effective and efficient connection between doctors and patients. The system enables important patient information to be available both to the doctor and patients at the time of need. It will no doubt provide a smart and alternative option to doctor who wants to provide best care to patient with the use of mobile technology.

With this self-developed CMS, it enables us to replicate our service excellence to regional areas in Asia which is mostly in need of our services. We have plans to establish new centres in Malaysia, Taiwan, Singapore and other ASEAN countries.

We have also spinned off our R&D team to form a startup company in The Science Park in Hong Kong, which is developing early cancer detection for cervical cancer.

Corporate Activities
As a member of the Hong Kong Chamber of Small and Medium Business, Neo-Health Group have been awarded with the ‘Best SME’s Awards’ in 2016 along with many other recognized prizes both in Hong Kong and abroad. This year, we are celebrating the eleventhyear anniversary of Neo-Health Group and although we have a relatively young team of staffs, we are sure to be energetic, adaptive to new changes and challenges we face in the medical field.

Neo-Health Group provides a flexible off duty hour for our staff members who wish to further pursue a subject of their interests, as employees develop skill sets that allow them to undertake a great variety of work, we have overseen an improvement on productivity and leadership abilities.